TAMPERE, Finland, May 26, 2023 /PRNewswire/ — The Annual General Meeting of Bioretec Ltd was held on 26 May 2023 in Tampere, Finland. The Annual General Meeting approved the financial statements for the financial year 1 January-31 December 2022 and resolved to discharge the members of the Board of Directors and the CEO from liability … Read more
DUBLIN, May 26, 2023 /PRNewswire/ — The “Next-Generation Breast Cancer Diagnostic and Screening Market – A Global Market and Regional Analysis: Focus on Technology, Cancer Sub-Type, Biomarker, Offering, End User, and Country Analysis – Analysis and Forecast, 2023-2032” report has been added to ResearchAndMarkets.com’s offering. The global next-generation breast cancer diagnostic and screening market was … Read more
SHANGHAI, May 26, 2023 /PRNewswire/ — Pulse Medical Technology, Inc. (Pulse Medical) 4th generation μFR® system has received an FDA Breakthrough Device designation. Pulse Medical, founded in 2015, located in Shanghai, China, is dedicated to developing innovative technology for precise diagnosis and optimal treatment of patients with pan-vascular disease. Pulse Medical has been pioneering and … Read more
CAMBRIDGE, Mass., May 26, 2023 /PRNewswire/ — The Eureka Clinical AI platform, from ConcertAI’s TeraRecon, the advanced visualization and clinical AI SaaS category leader, now provides clinicians with the state-of-the-art clinical artificial intelligence and deep learning technology necessary to bring fast and accurate prostate cancer detection and diagnosis using bpMRI and AI in partnership with Bot Image, … Read more
Huma’s innovative approach to medical research cited in Lord James O’Shaughnessy’s review for clinical trials improvement in the UK The review is part of a new widespread policy approach to ignite the UK’s life sciences sector Innovating clinical trials using digital technologies such as Huma’s platforms can make them more accessible, more diverse, faster to … Read more
COPENHAGEN, Denmark, May 25, 2023 /PRNewswire/ — Curasight A/S (“Curasight” or “the Company” – TICKER: CURAS) hereby publishes the interim report Q1 2023. The interim report is available as an attached file to this release and on the Company’s website. Below is a summary of the report. Curasight’s CEO Ulrich Krasilnikoff comments: “During the first quarter … Read more
Dr. Winterbottom will serve the role of SVP, Product Development & Manufacturing Operations RIVERDALE, Md., May 24, 2023 /PRNewswire/ — Medcura, Inc. has added Dr. Neil Winterbottom to its leadership team to accelerate the spine indication approval and commercialization of LifeGel™, Medcura’s flagship surgical hemostat. Medcura, Inc. is delighted to welcome biochemist Dr. Neil Winterbottom … Read more
COVINA, Calif., May 24, 2023 /PRNewswire/ — According to Prophecy Market Insights Orthodontics Market accounted for US$ 5.4 billion in 2022 and is estimated to be US$ 20.0 billion by 2032 and is anticipated to register a CAGR of 18.8%. Orthodontics is a specialized branch of dentistry that focuses on the diagnosis, prevention, and treatment of … Read more
The global patient simulator market is driven by factors such as rising focus on patient safety, technological advancement, and increase in awareness regarding simulation based education. PORTLAND, Ore., May 24, 2023 /PRNewswire/ — Allied Market Research published a report, titled, “Patient Simulator Market by Product Type (Adult Patient Simulator, Infant Simulator, and Childbirth Simulator), Technology … Read more
Nach den Übernahmen von DS InPharmatics (DSI) im Jahr 2021 und Zwiers Regulatory Consultancy im Jahr 2022 baut die ProductLife Group (PLG), ein globaler Anbieter von regulatorischen und Compliance-Dienstleistungen für die Life-Science-Branche, ihre Kapazitäten zur Unterstützung der Produktentwicklungsaktivitäten ihrer Kunden durch die Übernahme des in der Schweiz ansässigen Unternehmens Cilatus Biopharma Consulting und des in … Read more